Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
John F. Ryan, Lauren M. Rosati, Vincent P. Groot, Dung T. Le, Lei Zheng, Daniel A. Laheru, Eun J. Shin, Juan Jackson, Joseph Moore, Amol K. Narang, Joseph M. Herman
Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16427-16436
Sarah Sheilds, Emer Conroy, Tony O'Grady, Alo McGoldrick, Kate Connor, Mark P. Ward, Zivile Useckaite, Eugene Dempsey, Rebecca Reilly, Yue Fan, Anthony Chubb, David Gomez Matallanas, Elaine W. Kay, Darran O'Connor, Amanda McCann, William M. Gallagher, Judith A. Coppinger
Published Mar 20, 2018 · Vol. 9, No. 21 · pp. 15673-15690
Gabriel von Waldenfels, Sibylle Loibl, Jenny Furlanetto, Anna Machleidt, Bianca Lederer, Carsten Denkert, Claus Hanusch, Sherko Kümmel, Gunter von Minckwitz, Andreas Schneeweiss, Michael Untch, Kerstin Rhiem, Peter A. Fasching, Jens-Uwe Blohmer
Published Mar 16, 2018 · Vol. 9, No. 20 · pp. 15168-15179